SOD2 Alleviates Hearing Loss Induced by Noise and Kanamycin in Mitochondrial DNA4834-deficient Rats by Regulating PI3K/MAPK Signaling

Abstract

Superoxide dismutase 2 (SOD2)-mediated gene therapy has significant protective effects against kanamycin-induced hearing loss and hair cell loss in the inner ear, but the underlying mechanisms are still unclear. Herein, an in vivo aging model of mitochondrial DNA (mtDNA)4834 deletion mutation was established using D-galactose, and the effects of noise or kanamycin on inner ear injury was investigated. Rats subjected to mtDNA4834 mutation via D-galactose administration showed hearing loss characterized by the disruption of inner ear structure (abnormal cell morphology, hair cell lysis, and the absence of the organ of Corti), increased SOD2 promoter methylation, and an increase in the degree of apoptosis. Exposure to noise or kanamycin further contributed to the effects of D-galactose. SOD2 overexpression induced by viral injection accordingly counteracted the effects of noise and kanamycin and ameliorated the symptoms of hearing loss, suggesting the critical involvement of SOD2 in preventing deafness and hearing-related conditions. The PI3K and MAPK signaling pathways were also regulated by noise/kanamycin exposure and/or SOD2 overexpression, indicating that they may be involved in the therapeutic effect of SOD2 against age-related hearing loss.

Keywords

hearing loss / methylation / mtDNA4834 deletion mutation / superoxide dismutase 2

References

[1] GourevitchB, EdelineJM, OccelliF, et al.. Is the din really harmless? Long-term effects of non-traumatic noise on the adult auditory system. Nat Rev Neurosci, 2014, 15(7): 483-491

[2] Halevi-KatzDN, YaakobiE, Putter-KatzH. Exposure to music and noise-induced hearing loss (NIHL) among professional pop/rock/jazz musicians. Noise Health, 2015, 17(76): 158-164

[3] DingT, YanA, LiuK. What is noise-induced hearing loss?. Br J Hosp Med (Lond), 2019, 80(9): 525-529

[4] LeTN, StraatmanLV, LeaJ, et al.. Current insights in noise-induced hearing loss: a literature review of the underlying mechanism, pathophysiology, asymmetry, and management options. J Otolaryngol Head Neck Surg, 2017, 46(1): 41

[5] LibermanMC. Noise-induced and age-related hearing loss: new perspectives and potential therapies. F1000Res, 2017, 6: 927

[6] SagwaEL, RuswaN, MavhungaF, et al.. Comparing amikacin- and kanamycin-induced hearing loss in multidrug-resistant tuberculosis treatment under programmatic conditions in a Namibian retrospective cohort. BMC Pharmacol Toxicol, 2015, 16: 36

[7] Wrzesniok D, Rok J, Beberok A, et al. Kanamycin induces free radicals formation in melanocytes: An important factor for aminoglycosides ototoxicity. J Cell Biochem, 2018, doi: https://doi.org/10.1002/jcb.26817

[8] NieC, XiangM, ShenC, et al.. The spiral ganglion degeneration and the expression of EFR3A in the cochlea of the deaf mice induced by co-administration of kanamycin and furosemide. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi (Chinese), 2014, 49(11): 930-936

[9] SakamotoT, ImaiH. Hydrogen peroxide produced by superoxide dismutase SOD-2 activates sperm in Caenorhabditis elegans. J Biol Chem, 2017, 292(36): 14804-14813

[10] ShaSH, ZajicG, EpsteinCJ, et al.. Overexpression of copper/zinc-superoxide dismutase protects from kanamycin-induced hearing loss. Audiol Neurootol, 2001, 6(3): 117-123

[11] KawamotoK, ShaSH, MinodaR, et al.. Antioxidant gene therapy can protect hearing and hair cells from ototoxicity. Mol Ther, 2004, 9(2): 173-181

[12] HerstPM, RoweMR, CarsonGM, et al.. Functional Mitochondria in Health and Disease. Front Endocrinol (Lausanne), 2017, 8: 296

[13] PogozelskiWK, HamelCJ, WoellerCF, et al.. Quantification of total mitochondrial DNA and the 4977-bp common deletion in Pearson’s syndrome lymphoblasts using a fluorogenic 5′-nuclease (TaqMan) real-time polymerase chain reaction assay and plasmid external calibration standards. Mitochondrion, 2003, 2(6): 415-427

[14] ChenB, ZhongY, PengW, et al.. Age-related changes in the central auditory system: comparison of D-galactose-induced aging rats and naturally aging rats. Brain Res, 2010, 1344: 43-53

[15] KongWJ, WangY, WangQ, et al.. The relation between D-galactose injection and mitochondrial DNA 4834 bp deletion mutation. Exp Gerontol, 2006, 41(6): 628-634

[16] FilserN, MargueC, RichterC. Quantification of wildtype mitochondrial DNA and its 4.8-kb deletion in rat organs. Biochem Biophys Res Commun, 1997, 233(1): 102-107

[17] LebrechtD, GeistA, KetelsenUP, et al.. Dexrazoxane prevents doxorubicin-induced long-term cardiotoxicity and protects myocardial mitochondria from genetic and functional lesions in rats. Br J Pharmacol, 2007, 151(6): 771-778

[18] LebrechtD, SetzerB, RohrbachR, et al.. Mitochondrial DNA and its respiratory chain products are defective in doxorubicin nephrosis. Nephrol Dial Transplant, 2004, 19(2): 329-336

[19] YangHC, DeleuzeS, ZuoY, et al.. The PPARgamma agonist pioglitazone ameliorates aging-related progressive renal injury. J Am Soc Nephrol, 2009, 20(11): 2380-2388

[20] YueZY, DongH, WangYF, et al.. Propofol prevents neuronal mtDNA deletion and cerebral damage due to ischemia/reperfusion injury in rats. Brain Res, 2015, 1594: 108-114

[21] WangJ, YuanL, XiaoH, et al.. Momordin Ic induces HepG2 cell apoptosis through MAPK and PI3K/Akt-mediated mitochondrial pathways. Apoptosis, 2013, 18(6): 751-765

[22] YuanL, WangJ, XiaoH, et al.. MAPK signaling pathways regulate mitochondrial-mediated apoptosis induced by isoorientin in human hepatoblastoma cancer cells. Food Chem Toxicol, 2013, 53: 62-68

[23] CarelliV, ChanDC. Mitochondrial DNA: impacting central and peripheral nervous systems. Neuron, 2014, 84(6): 1126-1142

[24] El-HattabAW, ScagliaF. Mitochondrial DNA depletion syndromes: review and updates of genetic basis, manifestations, and therapeutic options. Neurotherapeutics, 2013, 10(2): 186-198

[25] SeidmanMD, BaiU, KhanMJ, et al.. Mitochondrial DNA deletions associated with aging and presbyacusis. Arch Otolaryngol Head Neck Surg, 1997, 123(10): 1039-1045

[26] BaiU, SeidmanMD, HinojosaR, et al.. Mitochondrial DNA deletions associated with aging and possibly presbycusis: a human archival temporal bone study. Am J Otol, 1997, 18(4): 449-453

[27] ZhaoXY, SunJL, HuYJ, et al.. The effect of overexpression of PGC-1alpha on the mtDNA4834 common deletion in a rat cochlear marginal cell senescence model. Hear Res, 2013, 296: 13-24

[28] KongWJ, HuYJ, WangQ, et al.. The effect of the mtDNA4834 deletion on hearing. Biochem Biophys Res Commun, 2006, 344(1): 425-430

[29] YuJ, WangY, LiuP, et al.. Mitochondrial DNA common deletion increases susceptibility to noise-induced hearing loss in a mimetic aging rat model. Biochem Biophys Res Commun, 2014, 453(3): 515-520

[30] OhlemillerKK, Rybak RiceME, RosenAD, et al.. Protection by low-dose kanamycin against noise-induced hearing loss in mice: dependence on dosing regimen and genetic background. Hear Res, 2011, 280(1–2): 141-147

[31] MartoneT, GiordanoP, DagnaF, et al.. Nestin expression and reactive phenomena in the mouse cochlea after kanamycin ototoxicity. Eur J Neurosci, 2014, 39(11): 1729-1741

[32] HashimotoK, HickmanTT, SuzukiJ, et al.. Protection from noise-induced cochlear synaptopathy by virally mediated overexpression of NT3. Sci Rep, 2019, 9(1): 15362

[33] UmugireA, LeeS, KimD, et al.. Avenanthramide-C prevents noise- and drug-induced hearing loss while protecting auditory hair cells from oxidative stress. Cell Death Discov, 2019, 5: 115

[34] LiuY, YuY, ChuH, et al.. 17-DMAG induces Hsp70 and protects the auditory hair cells from kanamycin ototoxicity in vitro. Neurosci Lett, 2015, 588: 72-77

[35] SchmitzHM, JohnsonSB, SantiPA. Kanamycinfurosemide ototoxicity in the mouse cochlea: a 3-dimensional analysis. Otolaryngol Head Neck Surg, 2014, 150(4): 666-672

[36] HuYJ, KongWJ, WangQ, et al.. Sensitivity to the ototoxicity of kanamycin of the rat model for mimetic aging in the inner ear. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi (Chinese), 2008, 43(1): 58-61

[37] ZelkoIN, MarianiTJ, FolzRJ. Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic Biol Med, 2002, 33(3): 337-349

[38] TadrosSF, D’SouzaM, ZhuX, et al.. Gene expression changes for antioxidants pathways in the mouse cochlea: relations to age-related hearing deficits. PloS one, 2014, 9(2): e90279

[39] KroemerG, GalluzziL, BrennerC. Mitochondrial membrane permeabilization in cell death. Physiol Rev, 2007, 87(1): 99-163

[40] MorrillS, HeDZZ. Apoptosis in inner ear sensory hair cells. J Otol, 2017, 12(4): 151-164

[41] TsurutaF, MasuyamaN, GotohY. The phosphatidylinositol 3-kinase (PI3K)-Akt pathway suppresses Bax translocation to mitochondria. J Biol Chem, 2002, 277(16): 14 040-14 047

[42] FuldaS. Modulation of mitochondrial apoptosis by PI3K inhibitors. Mitochondrion, 2013, 13(3): 195-198

[43] DinhCT, GoncalvesS, BasE, et al.. Molecular regulation of auditory hair cell death and approaches to protect sensory receptor cells and/or stimulate repair following acoustic trauma. Front Cell Neurosci, 2015, 9: 96

[44] Van RossomS, Op de BeeckK, HristovskaV, et al.. The deafness gene DFNA5 induces programmed cell death through mitochondria and MAPK-related pathways. Front Cell Neurosci, 2015, 9: 231

[45] YangCH, SchrepferT, SchachtJ. Age-related hearing impairment and the triad of acquired hearing loss. Front Cell Neurosci, 2015, 9: 276